Brian Guerrieri Email and Phone Number

Manage sales of Purified Cortrophin Gel throughout Western PA, Central OH, Northern WV, and Western NY. Cortrophin Gel is a prescription medicine injected subcutaneously or intramuscularly. For Ophthalmology, it is indicated for severe acute or chronic allergic and inflammatory conditions affecting the eye and its adnexa, such as: allergic conjuctivitis, keratitis, iritis and iridocyclitis, diffuse posterior uveitis and choroiditis, optic neuritis, chorioretinitis, and anterior segment inflammation.

Managed sales from 2023 launch of DAYBUE (trofinetide) to Pediatrics, PED-Neuro, and Neurologists. DAYBUE is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) specifically indicated for Rett syndrome in adults and pediatric patients two years of age and older. Responsible for account management at Academic Institutions such as UPMC, AHN, Geisinger, Penn State Health, and WVU. Territory encompasses all of Western to Central PA and down to Southern WV.

Managed sales from 2020 launch of TEPEZZA to Oculoplastics, Neuro-Ophthalmologists, Ophthalmologists, and Endocrinologists. TEPEZZA is an insulin-like growth factor-1 receptor inhibitor indicated for the rare disease treatment of Thyroid Eye Disease. Responsible for account management at Eye Center of Excellences in Academic Institutions such as UPMC, AGH, and WVU. Territory encompasses all of Western PA to Erie and Northern WV.

Managed sales from 2013 launch of Adempas, an oral soluble guanylate cyclase stimulator to pulmonologist, cardiologist, and critical care physicians for rare disease treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Responsible for account managment in Pulmonary Hypertension Centers (UPMC & AHN) in Pittsburgh, PA. Territory also encompasses Cleveland, OH and Morgantown, WV.

Launched and managed sales of Exparel, a single dose wound infiltration local anesthetic to surgical physicians in a territory encompassing Western Pennsylvania.

Managed sales of Brevibloc, an IV-administered beta blockade to acute care physicians in the ICU, CCU, Neuro ICU, and ER. Territory encompassed Western Pennsylvania.

Launched and managed sales of Angiomax, an IV-administered anticoagulant, and Cleviprex, an IV-administered antihypertensive to interventional cardiologists and acute care physicians. Territory encompassed Western Pennsylvania, Eastern OH and Northern West Virginia.

Product launches of Celebrex and Axert. Managed sales also of Ambien and Covera. Business Development Coordinator Mid-Central Region. General Pittsburgh Territory.

Sales of water treatment specialty chemicals in the Basic Industry Group, primarily to the automotive and steel industry.

Researched, quality controlled, and formulated new coatings and compounds used in multiple industries such as paint and packaging.